Evidence map›Paper›PMID 37598213›Full record

ArticleNature communications2023

Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population.

Margaret L Lind, Murilo Dorion, Amy J Houde, Mary Lansing, Sarah Lapidus, Russell Thomas, Inci Yildirim, Saad B Omer, Wade L Schulz, Jason R Andrews and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Margaret L LindDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. Margaret.Lind@yale.edu.ORCID http://orcid.org/0000-0002-1572-4074
Murilo DorionDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Amy J HoudeConnecticut Department of Correction, Wethersfield, CT, USA.
Mary LansingConnecticut Department of Correction, Wethersfield, CT, USA.
Sarah LapidusDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Russell ThomasDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Inci YildirimDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-8631-0020
Saad B OmerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Wade L SchulzDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-2048-4028
Jason R AndrewsDivision of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-5967-251X
Matt D T HitchingsDepartment of Biostatistics, College of Public Health & Health Professions, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0003-2327-3557
Byron S KennedyConnecticut Department of Correction, Wethersfield, CT, USA.
Robert P RichesonConnecticut Department of Correction, Wethersfield, CT, USA.
Derek A T Cummings *Department of Biology, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-9437-1907
Albert I Ko *Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. Albert.Ko@yale.edu.ORCID http://orcid.org/0000-0001-9023-2339
Yale University · USUniversity of Florida · USStanford University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Immunological drivers of the transition from epidemicity to endemicity of SARS-CoV-2 in a high transmission LMIC settingR01AI174105 · NIAID · YALE UNIVERSITY · PI Federico Costa, Derek A Cummings · 2023 to 2026
$3.0M
Identifying and evaluating prevention strategies for COVID-19 in correctional facilitiesK99AI177945 · NIAID · YALE UNIVERSITY · PI LIND, MARGARET · 2023 to 2024
$127k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS K99 AI177945NIAID NIH HHS R01 AI174105
6 · The paper itself

Abstract

Whether SARS-CoV-2 infection and COVID-19 vaccines confer exposure-dependent ("leaky") protection against infection remains unknown. We examined the effect of prior infection, vaccination, and hybrid immunity on infection risk among residents of Connecticut correctional facilities during periods of predominant Omicron and Delta transmission. Residents with cell, cellblock, and no documented exposure to SARS-CoV-2 infected residents were matched by facility and date. During the Omicron period, prior infection, vaccination, and hybrid immunity reduced the infection risk of residents without a documented exposure (HR: 0.36 [0.25-0.54]; 0.57 [0.42-0.78]; 0.24 [0.15-0.39]; respectively) and with cellblock exposures (0.61 [0.49-0.75]; 0.69 [0.58-0.83]; 0.41 [0.31-0.55]; respectively) but not with cell exposures (0.89 [0.58-1.35]; 0.96 [0.64-1.46]; 0.80 [0.46-1.39]; respectively). Associations were similar during the Delta period and when analyses were restricted to tested residents. Although associations may not have been thoroughly adjusted due to dataset limitations, the findings suggest that prior infection and vaccination may be leaky, highlighting the potential benefits of pairing vaccination with non-pharmaceutical interventions in crowded settings.

Indexed as

COVID-19PrisonersCOVID-19 VaccinesHumansSARS-CoV-2VaccinationCOVID-19 Vaccines

Identifiers

PMID37598213
PMCPMC10439918
OpenAlexW4385999523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.